Tag: Pneumonia
PCV13 Predicted to Be Cost Saving Versus PCV7
Although 13-valent pneumococcal vaccine is more costly than PCV7, net cost savings expected
Community-Acquired Pneumonia Confers Long-Term Risk
High risk of long-term adverse events versus general population, irrespective of age
Macrolide Resistance Doesn’t Impact Pneumonia Outcomes
Patients hospitalized with macrolide-resistant S. pneumoniae not more severely ill at presentation
ATS: Risk of Pneumonia Up With Inhaled Corticosteroids in COPD
Observational studies show reduction in odds of pneumonia-associated, all-cause mortality
DPP-4 Inhibitors Not Tied to Pneumonia Hospitalizations
Findings among new users of antidiabetic drugs from 2007 to 2012
Outcomes No Worse for Macrolide-Resistant Pneumonia
Macrolide-resistance has no effect on outcomes as a function of compliance with current tx guidelines
Interventions Up Blood Culture Ordering in Pediatric Pneumonia
Increase in blood cultures for kids hospitalized with community-acquired pneumonia; no impact on LOS
Real-Time Decision Support Tool Aids ER Pneumonia Patients
Post deployment, significantly lower mortality in patients with community-acquired pneumonia
Use of Anticholinergic Meds May Up Pneumonia Risk for Elderly
But more research is needed
Incidence of Viral Pneumonia Up in Young Children
66 percent of pneumonia cases in more than 2,000 children studied caused by viruses alone
